CEL-SCI Corp

Finanzen von CEL-SCI Corp (CVM)

$1.425

+0.057 (+4.01%)Zum Schluss

Profitabilität und Margen von CVM

Evaluating the bottom line, CEL-SCI Corp maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -252.53%, provide a clear picture of how effectively CVM converts its operational activities into shareholder value.

CVM im Vergleich zur Peergroup

In the context of the broader market, CVM competes directly with industry leaders such as EVAX and PLRZ. With a market capitalization of $25.07M, it holds a significant position in the sector. When comparing efficiency, CVM's gross margin of N/A stands against EVAX's N/A and PLRZ's N/A. Such benchmarking helps identify whether CEL-SCI Corp is trading at a premium or discount relative to its financial performance.

Finanzielle Entwicklung von CEL-SCI Corp

CVM has faced substantial financial losses, with a net income of -$5,667,525 in Q3 2026 and a gross profit of -$946,370. The company has a forward P/E ratio of 23.04, indicating that investors are expecting future growth despite current losses.

Financials

FY2026Q3
0.00
Total Revenue
FY2026Q3
YoY:
+1.25%
-5.56M
Operating Profit
FY2026Q3
YoY:
+0.05%
-5.67M
Net Income after Tax
FY2026Q3
YoY:
-65.44%
-0.47
EPS - Diluted
FY2026Q3
YoY:
+2.32%
-4.03M
Free Cash Flow
FY2021Q3
-95.68K
FCF Margin - %

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln